SCHEMBL531822

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL532019	0.92	POLB (0.51)	HPGDMEN1RAB9AKMT2AABL1
	SCHEMBL532007	0.81	KDR (0.53)	MEN1RAB9AKMT2AKDRL3MBTL1
	SCHEMBL532744	0.80	KDR (0.52)	ABL1ERN1KDRPDE3BPDE3A
	SCHEMBL532605	0.80	POLB (0.53)	HPGDABL1POLBPDE3BPDE3A
	SCHEMBL531713	0.78	KDR (0.58)	KDRPDE3BPDE3APARP1BRD4
	SCHEMBL532077	0.76	KDR (0.55)	KDRROCK1PDE3BPDE3APARP1
	SCHEMBL7001705	0.75	PARP1 (0.64)	MEN1KMT2AKDRPDE3BPDE3A
	SCHEMBL25666545	0.75	ABL1 (0.72)	HPGDMEN1RAB9AKMT2AABL1
	SCHEMBL531913	0.73	PARP1 (0.59)	HPGDRAB9AERN1KDRJAK2
	SCHEMBL28860346	0.72	HPGD (1.00)	HPGDMEN1RAB9AKMT2AERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.